Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on S 3 dimethylamino 1 (2 thienyl) 1 propanol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110964703B reveals high-efficiency ketoreductase for duloxetine intermediate. Achieve cost reduction and supply reliability in pharmaceutical manufacturing.
Patent CN102285961B details a cost-effective racemization method for duloxetine intermediates, enhancing yield and reducing environmental impact for pharmaceutical manufacturing.